Health CarePharmaceuticals & Biotechnology
  • Price (USD)68.38
  • Today's Change1.64 / 2.46%
  • Shares traded3.17m
  • 1 Year change-15.75%
  • Beta0.7203
Data delayed at least 15 minutes, as of Nov 26 2021 18:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Friday, Incyte Corp (INCY:NSQ) closed at 68.38, 10.45% above the 52 week low of 61.91 set on Nov 02, 2021.
52-week range
61.91Nov 02 2021101.47Jan 25 2021
Markit short selling activity
Previous close66.74
Average volume1.90m
Shares outstanding220.89m
Free float217.55m
P/E (TTM)28.31
Market cap15.10bn USD
EPS (TTM)2.41
Data delayed at least 15 minutes, as of Nov 26 2021 18:00 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.